FEND for TB
FEND for TB
批准号:
10409690
负责人:
David Alland
金额:
$416.72万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-04 至 2023-05-31
关键词:
AddressAdultAgeAlgorithmsBacille Calmette-Guerin vaccinationBiological AssayCaringCause of DeathCharacteristicsChildChildhoodChinaClinical ResearchClinical SciencesCollaborationsCommunicable DiseasesCosts and BenefitsCountryDataDetectionDiabetes MellitusDiagnosisDiagnosticDiagnostic testsDiagnostics ResearchDrug resistanceDrug resistance in tuberculosisEconomicsEnrollmentEnsureEvaluationExposure toFeedbackFoundationsFundingGenus MycobacteriumGood Clinical PracticeHIV InfectionsHealthHealth BenefitHealth systemIndiaLaboratoriesLeadershipLungMalnutritionModelingMulti-Drug ResistanceMycobacterium tuberculosisOutcomePatient CarePatientsPerformancePeruPharmaceutical PreparationsPoliciesPredispositionPulmonary TuberculosisReadinessReference StandardsResearchResearch DesignResearch PersonnelResistanceScience PolicySiteSouth AfricaSpecific qualifier valueSpecimenSputumTechnologyTestingTriageTuberculosisTuberculosis diagnosisUgandaUnited States National Institutes of HealthWorkbaseclinical diagnosticsclinical research sitecomorbiditycostcost effectivenessdesigndiagnostic accuracydiagnostic algorithmdiagnostic strategydiagnostic technologieseconomic evaluationexperiencefield studygood laboratory practiceimprovedinnovationinterestlow and middle-income countriesmathematical modelnovelnovel diagnosticspoint of carepopulation healthprogramsprospectiverecruitresponsesample collectionstatisticstransmission processtuberculosis diagnosticstuberculosis treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
In response to RFA-AI-19-030, Feasibility of Novel Diagnostics for TB in Endemic Countries
(FEND-TB) the leadership team has brought together a consortium of experienced investigators
and clinical sites and developed a research plan to address critical unmet TB diagnostic needs.
This program benefits from experience gained during the successful 7-year tenure of the NIH
DMID-funded TB-Clinical Diagnostics Research Consortium (TB-CDRC), with overlap in
leadership, investigators and sites. This program has been adapted in several ways to further
enhance capacity to meet the current challenges in the field -- the successful collaboration with
the Foundation for Innovative New Diagnostics (FIND) has been strengthened to now a full
partnership that will facilitate access to cutting edge technologies and alignment of FEND-TB work
with global stakeholder priorities; clinical study sites in India and Peru have been added to
accelerate recruitment and augment capacity to enroll patients with co-morbidities and drug-
resistance; inclusion of a mature analytic laboratory and revised technology evaluation strategy
that together allow for rational, nimble, step-wise evaluation of early-stage diagnostics; and
inclusion of mathematical modeling capacity to inform optimal diagnostic strategies in TB endemic
settings. This proposal will test two main hypotheses: A. Novel early stage TB diagnostics, that
target bacterial and/or host targets and will be ready for evaluation in the next five years, will have
performance characteristics suitable for point of care (POC)/near-care use for TB detection,
triage, or drug susceptibility testing. B. Rapid non-sputum diagnostics will provide ancillary
support as components of algorithms for the diagnosis of childhood TB as well as paucibacillary
pulmonary TB and extrapulmonary TB in adults. Specific Aims are: 1. To evaluate the diagnostic
accuracy of early stage diagnostic tests for tuberculosis. 2. To identify new early stage
diagnostics for evaluation, and to develop and implement for each a stepwise evaluation plan. 3.
To use economic analysis and transmission modelling to design optimal diagnostic algorithms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resources, Workforce Development, and Animal Models for the Rutgers RBL
-
批准号:10793863
-
项目类别:
-
资助金额:$397.07万
-
财政年份:2023
-
负责人:David Alland
-
依托单位:
Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL
-
批准号:10631469
-
项目类别:
-
资助金额:$191.33万
-
财政年份:2022
-
负责人:David Alland
-
依托单位:
Key Facility Upgrades for the Rutgers University RBL.
-
批准号:10393791
-
项目类别:
-
资助金额:$332.84万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10493254
-
项目类别:
-
资助金额:$265.83万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10271644
-
项目类别:
-
资助金额:$275.15万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10665016
-
项目类别:
-
资助金额:$265.83万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10907954
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Administrative Core
-
批准号:10493259
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Administrative Core
-
批准号:10271645
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Administrative Core
-
批准号:10665018
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
FEND for TB
-
批准号:10180898
-
项目类别:
-
资助金额:$395.47万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosis
-
批准号:10584487
-
项目类别:
-
资助金额:$81.26万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Bacteria and Host in TB Transmission
-
批准号:10390418
-
项目类别:
-
资助金额:$181.62万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Novel and Optimized Diagnostics for Pediatric TB
-
批准号:10673360
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Novel and Optimized Diagnostics for Pediatric TB
-
批准号:10905419
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Bacteria and Host in TB Transmission
-
批准号:10598015
-
项目类别:
-
资助金额:$169.71万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Simple and rapid POC detection for fungemia
-
批准号:10542776
-
项目类别:
-
资助金额:$76.47万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
FEND for TB
-
批准号:9981978
-
项目类别:
-
资助金额:$399.8万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
FEND for TB
-
批准号:10654567
-
项目类别:
-
资助金额:$394.33万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Novel and Optimized Diagnostics for Pediatric TB
-
批准号:10615049
-
项目类别:
-
资助金额:$108.88万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
海外基金